Medicine & Life Sciences

1. Venous Thrombosis 100%
2. Venous Thromboembolism 79%
3. Pulmonary Embolism 55%
4. Warfarin 47%
5. Low Molecular Weight Heparin 39%
6. fibrin fragment D 32%
7. Anticoagulants 32%
8. Dalteparin 20%
9. Hemorrhage 19%
10. Heparin 18%
11. Cohort Studies 17%
12. Outpatients 16%
13. Therapeutics 15%
14. International Normalized Ratio 14%
15. Ultrasonography 13%
16. Atrial Fibrillation 12%
17. Hip 11%
18. Thrombosis 11%
19. Confidence Intervals 11%
20. Randomized Controlled Trials 11%
21. Arthroplasty 10%
22. Compression Stockings 9%
23. Guidelines 9%
24. Cost-Benefit Analysis 9%
25. Hospital Emergency Service 8%
26. Impedance Plethysmography 8%
27. Intravenous Immunoglobulins 8%
28. Thrombophilia 8%
29. Prospective Studies 8%
30. Thromboembolism 8%
31. Thrombocytopenia 7%
32. Leg 7%
33. Knee Replacement Arthroplasties 7%
34. Placebos 6%
35. Nomograms 6%
36. Costs and Cost Analysis 6%
37. Vitamin K 6%
38. Hematology 6%
39. Lung 6%
40. Canada 6%
41. Recurrence 6%
42. Type 2 von Willebrand Disease 6%
43. Upper Extremity Deep Vein Thrombosis 5%
44. Practice Guidelines 5%
45. Patient Care 5%
46. Thrombotic Thrombocytopenic Purpura 5%
47. Immunoglobulins 5%
48. Safety 5%
49. Physicians 5%
50. recombinant FVIIa 5%